Novadaq to present at Needham Healthcare Conference



    TORONTO, June 3 /CNW/ - Novadaq(R) Technologies Inc. (TSX: NDQ), a
developer of real-time medical imaging systems and image guided therapies for
the operating room, today announced that Dr. Arun Menawat, President & CEO of
Novadaq, will present the corporate story, technology and highlights,
including an update on commercial development and the pipeline, at the Needham
Healthcare Conference. The conference runs Wednesday, June 11 through
Thursday, June 12 at the New York Palace Hotel.
    Dr. Menawat's presentation is on Thursday, June 12th at 9:30 a.m. and
will be webcast live from Novadaq's website at www.novadaq.com.

    About Novadaq Technologies

    Novadaq Technologies Inc. commercializes real-time imaging and image
guidance systems for use in the operating room. With one set of proprietary
core technologies, Novadaq's products have multiple applications. Novadaq's
SPY System enables cardiac surgeons to diagnose intra-operatively by visually
assessing coronary vasculature and bypass graft functionality during the
course of heart bypass surgery. The SPY System is also indicated for use
during other surgeries, such as cardiovascular, plastic, reconstructive, organ
transplant and urological procedures. SPY can be used to visualize blood
vessels, tumors, tumor margins and the lymphatic system. Novadaq introduced
PINPOINT(TM), its first minimally invasive imaging system for autofluorescence
in October 2007. PINPOINT allows surgeons to differentiate between healthy and
cancerous tissue in the lung and other hollow organs. Further expanding its
portfolio of minimally invasive products, Novadaq is developing SPYscope which
combines the typical features of a standard endoscope with the additional
capabilities of SPY imaging. Novadaq is the exclusive United States
distributor of PLC Medical's CO(2) HEART LASER System, used in the same
cardiac procedures as the SPY System. Novadaq also offers the OPTTX(R) System,
which leverages the company's core imaging technology and is designed for the
diagnosis, evaluation and treatment of wet Age-related Macular Degeneration
(AMD). For more information, please visit the company's website at
www.novadaq.com.

    Forward-looking Statements
    Certain statements included in this press release may be considered
forward-looking. Such statements involve known and unknown risks,
uncertainties and other factors that may cause actual results, performance or
achievements to be materially different from those implied by such statements,
and therefore these statements should not be read as guarantees of future
performance or results. All forward-looking statements are based on Novadaq's
current beliefs as well as assumptions made by and information currently
available to Novadaq and relate to, among other things, results of future
clinical tests of PINPOINT and the SPY System, anticipated financial
performance, business prospects, strategies, regulatory developments, market
acceptance and future commitments. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date
of this press release. Due to risks and uncertainties, including the risks and
uncertainties identified by Novadaq in its public securities filings actual
events may differ materially from current expectations. Novadaq disclaims any
intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.

    %SEDAR: 00022069E




For further information:

For further information: visit our website at www.novadaq.com, or
contact: Arun Menawat, PhD, MBA, President & CEO, Novadaq Technologies Inc.,
(905) 629-3822 x 202, amenawat@novadaq.com; Michael Moore, Investor Relations,
The Equicom Group, (416) 815-0700 x 241, mmoore@equicomgroup.com

Organization Profile

NOVADAQ TECHNOLOGIES INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890